Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
670.8 INR | +1.11% | -2.46% | -4.99% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 39.81 and 25.09 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.99% | 256M | - | ||
-18.17% | 8.55B | B+ | ||
+87.40% | 4.63B | C+ | ||
+16.31% | 2.98B | B- | ||
-3.15% | 2.65B | - | ||
-2.10% | 1.89B | C- | ||
-53.27% | 1.81B | B- | ||
-12.97% | 1.56B | A- | ||
+21.59% | 1.27B | B+ | ||
-47.96% | 1.07B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- KRSNAA Stock
- Ratings Krsnaa Diagnostics Limited